BRISTOL-MYERS SQUIBB’s CEFZIL WILL BE IN DRUG STORES BY FEBRUARY, DETAILING STARTS IMMEDIATELY; ORAL CEPHALOSPORIN ANTIBIOTIC PRODUCT APPROVED DEC. 24